United States· US:81052-138_4cc23694-63af-f9f1-e063-6394a90a4ce0
Cytalux
A pafolacianine product containing pafolacianine sodium, registered in United States by On Target Laboratories, Inc..
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- PAFOLACIANINE SODIUM
- Manufacturer
- On Target Laboratories, Inc.
- Country
- United States (US)
- ATC code
- V04CX10
- ATC class
- Pafolacianine
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 2
- ndc11810521381010 CARTON in 1 CARTON (81052-138-10) / 1 VIAL, SINGLE-DOSE in 1 CARTON / 1.6 mL in 1 VIAL, SINGLE-DOSE (81052-138-01)
- ndc1181052-138-10
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f99ee1ee-bdf8-4eb8-ab47-40a496cee959 GET /v1/drugs/f99ee1ee-bdf8-4eb8-ab47-40a496cee959?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "INTRAVENOUS",
"source": "ndc",
"strength": "3.2",
"substance": "PAFOLACIANINE SODIUM",
"productndc": "81052-138",
"dosage_form": "INJECTION",
"dea_schedule": null,
"strength_unit": "mg/1.6mL",
"application_number": "NDA214907",
"marketing_category": "NDA"
}See everything about pafolacianine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.